This blood-based genetic test uses DNA microarray analysis to assess the combined effects of multiple genetic variants associated with cardiovascular and metabolic health.
Nine genetic risk scores are reported:
- Coronary artery disease
- Hypertension
- Stroke
- Abdominal aortic aneurysm
- Atrial fibrillation
- Type 2 diabetes
- Hypercholesterolaemia
- Hypertriglyceridaemia
- Dyslipidaemia
The report provides:
- A polygenic risk score for each condition
- Comparison with the relevant reference population
- Population percentile and risk classification
- Average or increased genetic-risk results
These insights may support personalised prevention, monitoring and discussions with a healthcare professional. Polygenic risk scores are not diagnostic and cannot predict with certainty whether a condition will develop. Results should be considered alongside family history, lifestyle, medical history and other clinical information.
